S871 Incidence of Barrett’s Esophagus Following Sleeve Gastrectomy Compared to Patients With GERD

Introduction: Gastroesophageal reflux disease (GERD) is a well-established risk factor for the development of Barrett’s esophagus (BE), a premalignant condition characterized by metaplastic changes in the esophageal mucosa. Sleeve gastrectomy (SG) has been linked to an increased incidence of GERD and is therefore considered a risk factor for BE. In 2021, a meta-analysis by Qumseya, et al. suggested an increased long-term risk of BE in patients who underwent SG. Additionally, the SLEEVEPASS trial reported an increased incidence of GERD symptoms and erosive esophagitis (EE) in SG patients when compared with Roux-en-Y patients at 10-year follow-up. These findings informed the 2024 American Society for Gastrointestinal Endoscopy GERD guidelines, which recommend BE screening in all post-SG patients regardless of symptoms. However, due to the limited evidence supporting screening in this population, our study aims to characterize the incidence of GERD, EE, and BE in patients who have undergone SG to better inform future guidelines. Methods: This is a single-center retrospective case-control study comparing rates of EE and BE in adults with history of SG to controls without history of SG undergoing esophagogastroduodenoscopy (EGD) for GERD evaluation between 2015 and 2024. Patients were matched 1:1 by age (±5 years) and sex, with a total of 117 pairs. Exclusionary criteria included prior BE, alternative foregut surgery, and/or incomplete EGD data. Results: Of the 117 SG patients, 63 (54%) had no documented history of GERD prior to surgery. Among these patients, 58 (92%) developed de novo GERD symptoms following SG. Among patients without preexisting GERD, SG was not significantly associated with BE, EE, or Los Angeles Grade A esophagitis (LA-A) compared to those who underwent EGD for GERD. Older age was independently associated with higher odds of LA-A (P = 0.008) but was not associated with BE or EE. Conclusion: Our results suggest that SG is associated with an increased risk of developing GERD. However, SG was not significantly associated with BE, EE, or LA-A compared to GERD controls. Older age was independently linked to higher odds of LA-A, suggesting age may be a stronger risk factor than surgical status. Our results did not correspond with prior studies that suggest increased risk of EE, but are largely limited by our small sample size. Large scale longitudinal studies are needed to characterize the risk of EE and BE in patients who have undergone SG.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001130944.90747.ff
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S871 Incidence of Barrett’s Esophagus Following Sleeve Gastrectomy Compared to Patients With GERD

Carolyn Wilson, Shreya Chablaney, Anzalee Khan, Aike Qiao et al.
The American Journal of Gastroenterology
Esophageal Cancer Research and Treatment
article

S871 Incidence of Barrett’s Esophagus Following Sleeve Gastrectomy Compared to Patients With GERD

Carolyn Wilson, Shreya Chablaney, Anzalee Khan, Aike Qiao, Theodore M. Hill, Rita M. Knotts, Shaili Babbar, Eric F. Lock, Juan Cerezo, Christine J. Ren‐Fielding, Christian Urban, Anuraag Gopaluni
article en

Abstract

Introduction: Gastroesophageal reflux disease (GERD) is a well-established risk factor for the development of Barrett’s esophagus (BE), a premalignant condition characterized by metaplastic changes in the esophageal mucosa. Sleeve gastrectomy (SG) has been linked to an increased incidence of GERD and is therefore considered a risk factor for BE. In 2021, a meta-analysis by Qumseya, et al. suggested an increased long-term risk of BE in patients who underwent SG. Additionally, the SLEEVEPASS trial reported an increased incidence of GERD symptoms and erosive esophagitis (EE) in SG patients when compared with Roux-en-Y patients at 10-year follow-up. These findings informed the 2024 American Society for Gastrointestinal Endoscopy GERD guidelines, which recommend BE screening in all post-SG patients regardless of symptoms. However, due to the limited evidence supporting screening in this population, our study aims to characterize the incidence of GERD, EE, and BE in patients who have undergone SG to better inform future guidelines. Methods: This is a single-center retrospective case-control study comparing rates of EE and BE in adults with history of SG to controls without history of SG undergoing esophagogastroduodenoscopy (EGD) for GERD evaluation between 2015 and 2024. Patients were matched 1:1 by age (±5 years) and sex, with a total of 117 pairs. Exclusionary criteria included prior BE, alternative foregut surgery, and/or incomplete EGD data. Results: Of the 117 SG patients, 63 (54%) had no documented history of GERD prior to surgery. Among these patients, 58 (92%) developed de novo GERD symptoms following SG. Among patients without preexisting GERD, SG was not significantly associated with BE, EE, or Los Angeles Grade A esophagitis (LA-A) compared to those who underwent EGD for GERD. Older age was independently associated with higher odds of LA-A (P = 0.008) but was not associated with BE or EE. Conclusion: Our results suggest that SG is associated with an increased risk of developing GERD. However, SG was not significantly associated with BE, EE, or LA-A compared to GERD controls. Older age was independently linked to higher odds of LA-A, suggesting age may be a stronger risk factor than surgical status. Our results did not correspond with prior studies that suggest increased risk of EE, but are largely limited by our small sample size. Large scale longitudinal studies are needed to characterize the risk of EE and BE in patients who have undergone SG.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 48%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.